0001213900-26-027756
SEC filingOn March 13, 2026, 60 Degrees Pharmaceuticals, Inc. filed an updated legal opinion of counsel from Sichenzia Ross Ference Carmel LLP regarding the shares of common stock. The filing includes the opinion as Exhibit 5.1 and the related consent as Exhibit 23.1.